HER-2 ultra-low breast cancer: exploring the clinicopathological features and prognosis in a retrospective study.

Front Oncol · 2023 · PMC10472273 · PMID 37664018

Europe PMC DOI

hedged sentence

0.0680

closest p · 1.4× alpha

0.0680

boldest claim

The sentences

did not reach statistical significanceP = 0.068so close (0.05 < p ≤ 0.1)

The 5-year DFS survival curve of the HER-2 ultra-low and low groups had a trend of separation, and the difference did not reach statistical significance (P = 0.068; Figure 1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.